Liquid chromatography tandem mass spectrometry determination of free and conjugated estrogens in breast cancer patients before and after exemestane treatment

Analytica Chimica Acta

Volumn 806, Issue , 2014, Pages 172-179

  Zhao, Yuli ^a   Boyd, Jessica M ^a   Sawyer, Michael B ^a   Li, Xing Fang ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Breast cancer; Estrogen conjugates; Estrogens; LC MS MS; Serum; Urine

Indexed keywords

BREAST CANCER; ESTROGEN CONJUGATES; ESTROGENS; LC-MS/MS; SERUM; URINE;

BLOOD; DISEASES; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC POLYMERS; REGRESSION ANALYSIS;

PATIENT TREATMENT;

AROMATASE; CONJUGATED ESTROGEN; CREATININE; DANSYL CHLORIDE; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; ESTRADIOL 3,17 GLUCURONIDE; ESTRADIOL GLUCURONIDE; ESTRADIOL SULFATE; ESTRIOL; ESTRIOL 16 GLUCURONIDE; ESTRIOL GLUCURONIDE; ESTRIOL SULFATE; ESTROGEN; ESTRONE; ESTRONE GLUCURONIDE; ESTRONE SULFATE; EXEMESTANE; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN BLOOD LEVEL; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; ESTROGEN URINE LEVEL; FEMALE; HORMONE DETERMINATION; HORMONE INHIBITION; HUMAN; HUMAN CELL; IONIZATION; LIMIT OF DETECTION; LINEAR REGRESSION ANALYSIS; LIQUID CHROMATOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; STANDARD; TANDEM MASS SPECTROMETRY; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS;

BREAST CANCER; ESTROGEN CONJUGATES; ESTROGENS; LC-MS/MS; SERUM; URINE;

ANDROSTADIENES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL CONGENERS; ESTROGENS; FEMALE; HUMANS; POSTMENOPAUSE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84890124388     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2013.11.014     Document Type: Article

References (30)

1. Hankinson S.E., Eliassen A.H. The Journal of Steroid Biochemistry and Molecular Biology 2007, 106:24.
2. Blair I.A. Steroids 2010, 75:297.
3. Poortman J., Thijssen J.H., Schwarz F. Journal of Clinical Endocrinology & Metabolism 1973, 37:101.
4. Fishman J. Cancer Research 1982, 42:3277.
5. Raftogianis R., Creveling C., Weinshilboum R., Weisz J. Journal of the National Cancer Institute Monographs 2000, 113.
6. Guillemette C., Belanger A., Lepine J. Breast Cancer Research 2004, 6:246.
7. Zhu B.T., Conney A.H. Carcinogenesis 1998, 19:1.
8. Xu X., Veenstra T.D., Fox S.D., Roman J.M., Issaq H.J., Falk R., Saavedra J.E., Keefer L.K., Ziegler R.G. Analytical Chemistry 2005, 77:6646.
9. Qin F., Zhao Y.Y., Sawyer M.B., Li X.F. Analytical Chemistry 2008, 80:3404.
10. Huang J., Sun J.H., Chen Y.H., Song Y.M., Dong L.J., Zhan Q.M., Zhang R.P., Abliz Z. Analytica Chimica Acta 2012, 711:60.
11. Hu Y.L., Fan Y.F., Li G.K. Journal of Chromatography 2012, 1228:205.
12. Xu X., Keefer L.K., Ziegler R.G., Veenstra T.D. Nature Protocols 2007, 2:1350.
13. Franke A.A., Custer L.J., Morimoto Y., Nordt F.J., Maskarinec G. Analytical and Bioanalytical Chemistry 2011, 401:1319.
14. Taioli E., Im A., Xu X., Veenstra T.D., Ahrendt G., Garte S. Reproductive Biology and Endocrinology 2010, 8.
15. Fiers T., Casetta B., Bernaert B., Vandersypt E., Debock M., Kaufman J.M. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 2012, 893:57.
16. Ray J.A., Kushnir M.M., Bunker A., Rockwood A.L., Meikle A.W. Clinica Chimica Acta 2012, 413:1008.
17. Xu X., Roman J.M., Issaq H.J., Keefer L.K., Veenstra T.D., Zieger R.G. Analytical Chemistry 2007, 79:7813.
18. Guo T.D., Gu J.H., Soldin O.P., Singh R.J., Soldin S.J. Clinical Biochemistry 2008, 41:736.
19. Ziegler R.G., Faupel-Badger J.M., Sue L.Y., Fuhrman B.J., Falk R.T., Boyd-Morin J., Henderson M.K., Hoover R.N., Veenstra T.D., Keefer L.K., Xu X. Journal of Steroid Biochemistry and Molecular Biology 2010, 121:538.
20. Kaplan A., Jack R., Opheim K.E., Toivola B., Lyon A.W. Clinical Chemistry: Interpretation and Techniques 1995, Williams & Wilkins, Baltimore, MD. 4th ed.
21. Higa G.M. American Journal of Health System Pharmacy 2002, 59:2194.
22. Lonning P.E. Clinical Cancer Research 2005, 11:918S.
23. Hong Y.Y., Yu B., Sherman M., Yuan Y.C., Zhou D.J., Chen S.A. Molecular Endocrinology 2007, 21:401.
24. National Cancer Institute FDA approval for Exemestane 2006, URL: www.cancer.gov/cancertopics/druginfo/exemestane.
25. Moen M.D., Wagstaff A.J. American Journal of Cancer 2006, 5:259.
26. Geisler J., King N., Anker G., Ornati G., Di Salle E., Lonning P.E., Dowsett M. Clinical Cancer Research 1998, 4:2089.
27. Santen R.J., Leszczynski D., Tilsonmallet N., Feil P.D., Wright C., Manni A., Santner S.J. Annals of the New York Academy of Sciences 1986, 464:126.
28. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., Maloche C. Journal of Clinical Endocrinology & Metabolism 1996, 81:1460.
29. Santen R.J., Manni A., Harvey H., Redmond C. Endocrinology Reviews 1990, 11:221.
30. Lonning P.E., Ekse D. The Journal of Steroid Biochemistry and Molecular Biology 1995, 55:409.